Cancer Immunotherapy Getting Brainy: Visualizing the Distinctive CNS Metastatic Niche to Illuminate Therapeutic Resistance

The advent of cancer immunotherapy (CIT) and its success in treating primary and metastatic cancer may offer substantially improved outcomes for patients. Despite recent advancements, many malignancies remain resistant to CIT, among which are brain metastases, a particularly virulent disease with no...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Resist Updat
Main Authors: Owyong, Mark, Hosseini-Nassab, Niloufar, Efe, Gizem, Honkala, Alexander, van den Bijgaart, Renske J. E., Plaks, Vicki, Smith, Bryan Ronain
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5728435/
https://ncbi.nlm.nih.gov/pubmed/29145972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drup.2017.10.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados